Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Stryker Corporation (SYK) stocks in Canada

Learn how to easily invest in Stryker Corporation stocks.

Stryker Corporation (SYK) is a leading medical devices business based in the US. It opened the day at $282.62 after a previous close of $280.71. During the day the price has varied from a low of $280.93 to a high of $285.68. The latest price was $285.47 (25 minute delay). Stryker Corporation is listed on the NYSE and employs 51,000 staff. All prices are listed in US Dollars.

How to buy Stryker Corporation stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – SYK. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for Beginners

CIBC Investor's Edge


  • Easy to use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Finder Award

Interactive Brokers


  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Promoted for Free Trades

National Bank Direct Brokerage


  • Commission-free trading
  • Several account types available
  • Access to array of research tools

Stryker Corporation stock price (NYSE:SYK)

Use our graph to track the performance of SYK stocks over time.

Stryker Corporation shares at a glance

Information last updated 2023-03-31.
Open$282.62
High$285.68
Low$280.93
Close$285.47
Previous close$280.71
Change $4.76
Change % 1.6957%
Volume 1,810,569
Information last updated 2023-03-30.
52-week range$187.62 - $284.00
50-day moving average $266.45
200-day moving average $231.19
Wall St. target price$280.00
PE ratio 31.7443
Dividend yield $2.835 (1.08%)
Earnings per share (TTM) $6.17

Buy Stryker Corporation stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Available Asset Types Stock Trading Fee Account Fee Table description Signup Offer Offer
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95–$6.95
$0 if conditions met, or $100
An easy-to-use platform with access to a variety of tools to help you trade with confidence.
N/A
Get 100 free online stock or ETF trades and up to $3,000 cash back. Conditions apply.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
min $1.00, max 0.5%
$0
Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.
N/A
National Bank Direct Brokerage
Stocks, Bonds, Options, Mutual Funds, GICs
$0
$0 if conditions met, or $100
Get $0 commission on all transactions with promo code: finder
Get $0 commission on all transactions with promo code: finder
Questrade
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95 - $9.95
$0
Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.
Get $50 in free trades when you fund your account with a minimum of $1,000.
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.
Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.
Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.
loading

Is it a good time to buy Stryker Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Stryker Corporation price performance over time

Historical closes compared with the close of $285.47 from 2023-03-31

1 week (2023-03-24) 3.17%
1 month (2023-03-02) 8.92%
3 months (2022-12-30) 16.76%
6 months (2022-09-30) 40.94%
1 year (2022-03-29) N/A
2 years (2021-04-01) 17.50%
3 years (2020-04-02) 90.85%
5 years (2018-04-02) 82.70%

Is Stryker Corporation stock undervalued or overvalued?

Valuing Stryker Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Stryker Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Stryker Corporation financials

Revenue TTM $18.4 billion
Operating margin TTM 19.18%
Gross profit TTM $11.6 billion
Return on assets TTM 6.18%
Return on equity TTM 1497.48%
Profit margin 12.78%
Book value $43.88
Market capitalisation $105.1 billion

TTM: trailing 12 months

Stryker Corporation's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Stryker Corporation.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Stryker Corporation's total ESG risk score

Total ESG risk: 33.93

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Stryker Corporation's overall score of 33.93 (as at 01/01/2019) is pretty weak – landing it in it in the 71st percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Stryker Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Stryker Corporation's environmental score

Environmental score: 3.06/100

Stryker Corporation's environmental score of 3.06 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Stryker Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Stryker Corporation's social score

Social score: 14.68/100

Stryker Corporation's social score of 14.68 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Stryker Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Stryker Corporation's governance score

Governance score: 8.19/100

Stryker Corporation's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Stryker Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Stryker Corporation's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Stryker Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Stryker Corporation hasn't always managed to keep its nose clean.

Stryker Corporation share dividends

31%

Dividend payout ratio: 30.94% of net profits

Recently Stryker Corporation has paid out, on average, around 30.94% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.08% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Stryker Corporation shareholders could enjoy a 1.08% return on their shares, in the form of dividend payments. In Stryker Corporation's case, that would currently equate to about $2.835 per share.

While Stryker Corporation's payout ratio might seem fairly standard, it's worth remembering that Stryker Corporation may be investing much of the rest of its net profits in future growth.

Stryker Corporation's most recent dividend payout was on 28 April 2023. The latest dividend was paid out to all shareholders who bought their shares by 30 March 2023 (the "ex-dividend date").

Have Stryker Corporation's shares ever split?

Stryker Corporation's shares were split on a 2:1 basis on 17 May 2004. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Stryker Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Stryker Corporation shares which in turn could have impacted Stryker Corporation's share price.

Stryker Corporation share price volatility

Over the last 12 months, Stryker Corporation's shares have ranged in value from as little as $187.6183 up to $284. A popular way to gauge a stock's volatility is its "beta".

SYK.US volatility(beta: 0.93)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Stryker Corporation's is 0.9337. This would suggest that Stryker Corporation's shares are less volatile than average (for this exchange).

Stryker Corporation overview

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site